ADIR's new MMP and TNF-alpha production inhibitors described in recent patent Jan. 31, 2000 No Comments
Access to begin phase II trial of OraRinse for treatment and prevention of mucositis Jan. 31, 2000 No Comments
NYU School of Medicine and P&U establish anticancer drug discovery collaboration Jan. 31, 2000 No Comments
Schering-Plough seeks E.U. approval of Caelyx for treatment of advanced ovarian cancer Jan. 28, 2000 No Comments
Licensing opportunity from NIH: 5-lipoxygenase inhibitors as anticancer agents Jan. 28, 2000 No Comments